![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3962|9|2|63-72
ISSN: 1574-8901
Source: Recent Patents on Cardiovascular Drug Discovery, Vol.9, Iss.2, 2014-12, pp. : 63-72
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro
By Wang Yaning
Angiogenesis, Vol. 7, Iss. 4, 2004-12 ,pp. :